Company research
BIOFORCE NANOSCIENCES HOLDINGS, INC.
CIK 1310488Updated Nov 11, 2026
SecurityBFNH · OTC · equity
Name history
SILVER RIVER VENTURES, INC. · through Feb 24, 2006
BFNH price & chart
Loading TradingView…
OTC:BFNH on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
10-Q filing
Other Events
Items 8.01, 9.01
SCHEDULE 13D - filed by Nexus Capital Investments, Inc. regarding BIOFORCE NANOSCIENCES HOLDINGS, INC.
Unregistered Sales of Equity Securities
Items 3.02
4 filing
Show 5 more recent filings
Regulation FD Disclosure
Items 7.01, 9.01
Other Events
Items 8.01
10-Q filing
Other Events
Items 8.01, 9.01
Other Events
Items 8.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 784Source | 1,635Source | 2,388,075Source | 905Source | 667Source | 6,347Source | 13,799Source | 640Source | 786Source | 862Source | 638Source | 734Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 784Source | 1,635Source | 307Source | 905Source | 667Source | 6,347Source | 13,799Source | 640Source | 786Source | 862Source | 638Source | 734Source |
| Assets, CurrentUSD | 784Source | 1,635Source | 2,153,550Source | 905Source | 667Source | 6,347Source | 13,799Source | 640Source | 786Source | 862Source | 638Source | 734Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 500,722Source | 2,180,067Source | 84,767Source | 384,928Source | 2,065,075Source | 727,301Source | 275,041Source | 1,950,683Source | 619,329Source | 2,302,454Source | 1,819,868Source | 1,348,011Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 33,522Source | 29,272Source | 33,549Source | 33,522Source | 29,272Source | 33,522Source | 33,522Source | 29,272Source | 33,522Source | 29,272Source | 29,272Source | 29,272Source |
| Retained Earnings (Accumulated Deficit)USD | -162,293,512Source | -160,997,006Source | -162,275,846Source | -162,177,597Source | -160,874,982Source | -162,514,528Source | -162,054,816Source | -160,760,542Source | -162,412,117Source | -161,120,166Source | -160,629,729Source | -160,157,776Source |
| Stockholders' Equity Attributable to ParentUSD | -499,938Source | -2,178,432Source | 2,303,308Source | -384,023Source | -2,064,408Source | -720,954Source | -262,049Source | -1,950,043Source | -618,543Source | -2,301,592Source | -1,819,230Source | -1,347,277Source |
| Additional Paid in Capital, Common StockUSD | 161,760,052Source | 158,789,302Source | 162,061,305Source | 161,760,052Source | 158,781,302Source | 161,760,052Source | 161,760,052Source | 158,781,227Source | 161,760,052Source | 158,789,302Source | 158,781,227Source | 158,781,227Source |
| Liabilities and EquityUSD | 784Source | 1,635Source | 2,388,075Source | 905Source | 667Source | 6,347Source | 13,799Source | 640Source | 786Source | 862Source | 638Source | 734Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 500,722Source | 2,180,067Source | 84,767Source | 384,928Source | 2,065,075Source | 727,301Source | 275,041Source | 1,950,683Source | 619,329Source | 2,302,454Source | 1,819,868Source | 1,348,011Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 7,088Source | -15,215Source | -65,150Source | -61,250Source | -46,702Source | -68,389Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -1,527Source | 28,152Source | 65,074Source | 61,474Source | 46,606Source | 58,018Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 5,561Source | 12,937Source | -76Source | 224Source | -96Source | -10,371Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 784Source | 1,635Source | 307Source | 905Source | 6,347Source | 13,799Source | 786Source | 862Source | 638Source | 734Source |
| Additional Financial Items | ||||||||||||
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | 802,000Source | -801,193Source | 802,000Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | 10,165Source | 16,274Source | 118,580Source | 17,031Source | 11,983Source | 27,707Source | 66,951Source | 67,437Source | 48,953Source | 62,514Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -115,915Source | -122,024Source | 238,682Source | -122,781Source | -102,411Source | -935,457Source | -1,291,951Source | -490,437Source | -471,953Source | -485,514Source |
| Operating ExpensesUSD | — | — | 115,915Source | 122,024Source | 262,330Source | 122,781Source | 117,733Source | 133,457Source | 489,951Source | 490,437Source | 471,953Source | 485,514Source |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | —Source | — | — | — | — |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
| Nonoperating Income (Expense) | — | — | — | — | —Source | — | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | -262,330Source | -122,781Source | -117,733Source | -133,457Source | -489,951Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -115,915Source | -122,024Source | 238,682Source | -122,781Source | -102,411Source | -935,457Source | -1,291,951Source | -490,437Source | -471,953Source | -485,514Source |
| Earnings Per Share, BasicUSD per share | — | — | 0Source | 0Source | 0.01Source | 0Source | 0Source | -0.03Source | -0.04Source | -0.02Source | -0.02Source | -0.02Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0Source | 0Source | 0.01Source | 0Source | 0Source | -0.03Source | -0.04Source | -0.02Source | -0.02Source | -0.02Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 33,521,755Source | 29,271,755Source | 33,544,161Source | 33,521,755Source | 33,521,755Source | 32,246,755Source | 33,207,371Source | 29,271,755Source | 29,271,755Source | 29,271,755Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 33,521,755Source | 29,271,755Source | 33,544,161Source | 33,521,755Source | 33,521,755Source | 32,246,755Source | 33,207,371Source | 29,271,755Source | 29,271,755Source | 29,271,755Source |
| Additional Financial Items | ||||||||||||
| General and Administrative ExpenseUSD | — | — | 10,165Source | 16,274Source | 118,580Source | 17,031Source | 11,983Source | 27,707Source | 66,951Source | 67,437Source | 48,953Source | 62,514Source |
| Operating ExpensesUSD | — | — | 115,915Source | 122,024Source | 262,330Source | 122,781Source | 117,733Source | 133,457Source | 489,951Source | 490,437Source | 471,953Source | 485,514Source |
| Other ExpensesUSD | — | — | — | — | — | — | 0Source | 3,152Source | 4,075Source | — | — | — |
| Operating Income (Loss) | — | — | —Source | —Source | — | —Source | — | —Source | — | — | — | — |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
| Nonoperating Income (Expense) | — | — | — | — | —Source | — | —Source | —Source | — | — | — | — |